Article
Epidermal growth factor receptor mutations in 510 Finnish non--small-cell lung cancer patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jun 2014
Mäki-Nevala Satu, Rönty Mikko, Morel Mike, Gomez Maria, Dawson Zoe, Sarhadi Virinder Kaur, Telaranta-Keerie Aino, Knuuttila Aija, Knuutila Sakari
Abstract excerpt
INTRODUCTION: Among the driver gene mutations in non-small-cell lung cancer, mutations in epidermal growth factor receptor (EGFR) are the most important because of their predictive role in selecting patients eligible for targeted therapy. Our aim was to study EGFR mutations in a Finnish non-small-cell lung cancer cohort of 528 patients. METHODS: Mutation testing was conducted on DNA extracted from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.